Guide
Naltrexone: What It Is Used For and How It Works
By Naltrexone Reviews Editorial TeamUpdated 29 sourcesHow we check

On this page
Short answer
Naltrexone is a prescription medicine that blocks opioid receptors, FDA-approved in 1984 to block the effects of opioids and in 1994 for alcohol dependence. It comes as a generic 50 mg daily tablet or as Vivitrol, a 380 mg shot every 4 weeks. It is not an opioid or habit-forming, and you must be off opioids before starting.1-3
Key takeaways
- For alcohol, the benefit is modest. In pooled trials, for every 11 people who took the tablet instead of a placebo, 1 more avoided a return to heavy drinking.4
- You can start the tablets while still drinking, according to NIAAA, and drinking on naltrexone does not make you sick.2,5
- For opioid use disorder, daily pills showed no clear benefit over placebo in trials, largely because people stopped taking them, and the monthly shot is generally recommended instead.6,7
- After you stop, an opioid dose you once handled can kill you, because your tolerance has dropped.2
Naltrexone at a glance
| Attribute | Details |
|---|---|
| Generic name | Naltrexone hydrochloride (tablets); naltrexone (Vivitrol)2,3 |
| Drug class | Opioid antagonist (blocker), with no opioid agonist properties2 |
| FDA-approved for | Tablets: alcohol dependence, and blocking the effects of opioids. Vivitrol: alcohol dependence in people who can stop drinking before the first shot, and preventing relapse to opioid dependence after detox.2,3 |
| Usual dose | One 50 mg tablet a day for most people. Vivitrol: 380 mg into a buttock muscle every 4 weeks.2,3 Details: naltrexone dosage |
| Brand names | ReVia, the original tablet brand, is discontinued; tablets are sold as generics. Vivitrol is the only brand of the shot.8 More: naltrexone brand names |
| Controlled substance? | No; federal law excludes it from Schedule II9 |
| Boxed warning | None on the current tablet or Vivitrol labels2,3 |
| Pregnancy | No adequate studies in pregnant women; use only if the benefit justifies the risk2; see naltrexone and pregnancy |
| Under 18 | Safety not established2 |
| Cash price, October 17, 2026 | Tablets: set by your pharmacy; Vivitrol from $1,758.09 a shot. Full breakdown: naltrexone cost · Vivitrol cost10 |
Naltrexone at a glance
Generic name
Drug class
- Details
- Opioid antagonist (blocker), with no opioid agonist properties2
FDA-approved for
Usual dose
- Details
- One 50 mg tablet a day for most people. Vivitrol: 380 mg into a buttock muscle every 4 weeks.2,3 Details: naltrexone dosage
Brand names
- Details
- ReVia, the original tablet brand, is discontinued; tablets are sold as generics. Vivitrol is the only brand of the shot.8 More: naltrexone brand names
Controlled substance?
- Details
- No; federal law excludes it from Schedule II9
Boxed warning
Pregnancy
- Details
- No adequate studies in pregnant women; use only if the benefit justifies the risk2; see naltrexone and pregnancy
Under 18
- Details
- Safety not established2
Cash price, October 17, 2026
- Details
- Tablets: set by your pharmacy; Vivitrol from $1,758.09 a shot. Full breakdown: naltrexone cost · Vivitrol cost10
Two approved uses, three off-label or combination uses
| Use | Status | Form and dose | Read more |
|---|---|---|---|
| Alcohol use disorder | FDA-approved: tablets since 1994, Vivitrol since 20061,8 | 50 mg tablet daily, or the monthly shot | Naltrexone for alcohol use disorder |
| Opioid use disorder, after detox | FDA-approved: tablets since 1984 to block opioids, Vivitrol since 2010 to prevent relapse1,8 | The shot is generally preferred7 | Vivitrol |
| Taking it only before drinking (the Sinclair Method) | Off-label; the label's dosing is daily2 | A tablet taken only on drinking days, before drinking | The Sinclair Method |
| Low-dose naltrexone (LDN) for chronic pain, autoimmune and other conditions | Off-label11; no low-dose product is listed in the FDA drug directory, so it is compounded12 | Usually 0.5 to 6 mg a day, most often 4.5 mg11 | Low-dose naltrexone; what to avoid on LDN |
| Weight management | Approved only as Contrave, a combination with bupropion (2014)8,13 | Up to 32 mg naltrexone a day in extended-release tablets13 | Naltrexone and bupropion (Contrave) |
Two approved uses, three off-label or combination uses
Use: Alcohol use disorder
- Form and dose
- 50 mg tablet daily, or the monthly shot
- Read more
- Naltrexone for alcohol use disorder
Use: Opioid use disorder, after detox
Use: Taking it only before drinking (the Sinclair Method)
- Status
- Off-label; the label's dosing is daily2
- Form and dose
- A tablet taken only on drinking days, before drinking
- Read more
- The Sinclair Method
Use: Low-dose naltrexone (LDN) for chronic pain, autoimmune and other conditions
- Form and dose
- Usually 0.5 to 6 mg a day, most often 4.5 mg11
- Read more
- Low-dose naltrexone; what to avoid on LDN
Use: Weight management
- Form and dose
- Up to 32 mg naltrexone a day in extended-release tablets13
- Read more
- Naltrexone and bupropion (Contrave)
For alcohol, the American Psychiatric Association recommends offering naltrexone or acamprosate to people with moderate to severe alcohol use disorder who prefer medication or have not improved with other treatment.14 Disulfiram, off-label topiramate and the other pills to stop drinking are compared on their own page.
For LDN, a 2026 review of 105 studies found that early positive results from uncontrolled studies "were rarely replicated in placebo-controlled trials."11
How naltrexone works: it blocks opioid receptors
Naltrexone attaches to the body's opioid receptors, most tightly to the mu receptor, and does not switch them on.3 It competes with opioids for those receptors. While it is in place, heroin and opioid painkillers have little or no effect. In studies, a 50 mg tablet blocked the effects of 25 mg of injected heroin for as long as 24 hours; doubling or tripling the dose stretched that to about 48 or 72 hours.2
The block can be overpowered. Someone who takes large amounts of opioids to get past it can have a fatal overdose.2
Alcohol. How naltrexone lowers drinking is not fully understood; animal research points to the body's own opioid system.2 The working explanation is that it blocks the opioid receptors involved in the rewarding effects of drinking.5 In laboratory studies, people on naltrexone reported less craving and less stimulation from alcohol, and more sedation; the effects were small.15 What drinking feels like on it is covered on drinking on naltrexone, and the alcohol research on the AUD page.
What it does not do.
- It produces no high and no opioid effect, and it was not linked to tolerance or dependence.2
- It causes no Antabuse-like reaction to alcohol.2
- In someone dependent on opioids, it sets off withdrawal (see below).2
In the body. A tablet is absorbed quickly, with peak blood levels within an hour. The liver breaks down most of it on the first pass, and its main breakdown product, 6-beta-naltrexol, is also active.2
It helps with drinking modestly; for opioids the shot has the evidence
Alcohol. The tablet label sets expectations at "a modest improvement in the outcome of conventional treatment."2 Across pooled trials, 11 people needed to take naltrexone for 1 more to avoid a return to heavy drinking, and the 95% confidence interval ran from 5 to 41.4 Across 50 trials, heavy drinking was 17% less likely on naltrexone, with no statistically significant effect on whether people drank at all.16
Opioids. A Cochrane review of 13 trials (1,158 people) found daily pills no better than placebo, except in studies where people were made to take them.6 In a placebo-controlled trial of the Vivitrol shot after detox, people on it had confirmed opioid-free results in a median 90% of weeks, against 35% on placebo.17
The trials, including the negative ones, are covered one by one on does naltrexone work? When to expect a change is covered on how long naltrexone takes to work.
The FDA has approved a tablet and a shot, nothing else
Tablets. Seven generic naltrexone tablet approvals are listed as prescription products in Drugs@FDA.8 Why 50 mg is the only strength you will see is explained on naltrexone dosage. Former tablet brands (ReVia, Depade) and each one's status are listed on naltrexone brand names.
The shot. Vivitrol is made by Alkermes. An unbranded version distributed by Amneal is sold under the same FDA approval, so it is not a generic.18 A true generic from Teva was approved in 2023 and is now listed as discontinued.8 Pill and shot are compared on naltrexone vs Vivitrol.
Implants. Naltrexone pellets placed under the skin are not FDA-approved in the US: naltrexone implant.
Compounded versions. LDN capsules and some telehealth formulations are made by compounding pharmacies. Compounded drugs are not FDA-approved, and the FDA does not check their safety, effectiveness or quality before sale.12,19 How to tell them apart is explained on generic vs compounded naltrexone.
Opioids must be out of your system before the first dose
Opioids. Stop short-acting opioids, including tramadol, for at least 7 to 10 days first. After methadone or buprenorphine, withdrawal can be triggered for as long as 2 weeks.2 Opioid cough, cold and diarrhea medicines count. A clinic may check with a urine test or a naloxone challenge, but the label says no method is completely reliable.2 Withdrawal set off by naltrexone usually starts within 5 minutes, can last up to 48 hours, and has put people in hospital.2 For opioid use disorder, the tablet label starts with 25 mg, then 50 mg a day if there are no withdrawal signs.2
Alcohol. Some patient pages still say you must stop drinking and finish detox before the first tablet. US guidance for clinicians says naltrexone "can be started while a patient is still drinking," and it can be continued after a relapse.5,7 Vivitrol is different: its alcohol approval covers people who stop drinking before the first shot.3 If you drink heavily every day, stopping suddenly can be dangerous, so plan withdrawal with a clinician.
How long. England's NICE guideline starts the tablets after assisted withdrawal, stops them if drinking persists 4 to 6 weeks in, and otherwise prescribes them for up to 6 months, or longer if they are helping.20 Missed doses and schedules are covered on naltrexone dosage.
Most side effects are mild; the serious risks involve opioids and the liver
In an open-label safety study of about 570 people treated for alcohol use disorder, the most common new side effects were nausea (10%), headache (7%), dizziness (4%), nervousness (4%) and tiredness (4%).2 Overall, it is generally safe and well tolerated.7 The shot adds injection-site reactions.3 Rates against placebo, and what helps, are on naltrexone side effects and Vivitrol side effects.
-
Overdose after stopping. Tolerance falls, so a smaller opioid dose than before can be fatal. Read the full warning and keep naloxone at home.2
-
Liver. The label warns of hepatitis and liver injury. In placebo-controlled studies, doses up to 300 mg a day, several times the usual dose, injured the liver in a substantial share of people.2 FDA removed the boxed liver warning from the ReVia tablet label in October 2013.21 See naltrexone liver tests.
-
Mood. People taking it for alcohol or opioids should be watched for depression or suicidal thinking.2 If you have thoughts of suicide, call or text 988.22
-
Medicines that may not work. Opioid painkillers, cough medicines and diarrhea medicines may have little effect. Carry a card saying you take naltrexone.2 Taking it with disulfiram, which can also harm the liver, is not ordinarily recommended, and Contrave's label advises against adding other naltrexone products.2,13
-
Driving. It can cause dizziness, so wait to drive until you know how it affects you.2
Naltrexone is not naloxone, and it is not Suboxone
| Drug | What it does | Controlled substance? | More |
|---|---|---|---|
| Naltrexone (tablets, Vivitrol) | Daily or monthly blocker that helps prevent relapse | No9 | This page |
| Naloxone (Narcan and other sprays) | Rescue drug that reverses an opioid overdose; nasal sprays are sold over the counter23 | No9 | Naltrexone vs naloxone |
| Buprenorphine with naloxone (Suboxone) | Daily film under the tongue; buprenorphine partly switches opioid receptors on1 | Yes, Schedule III24 | Naltrexone vs Suboxone |
Naltrexone is not naloxone, and it is not Suboxone
Drug: Naltrexone (tablets, Vivitrol)
- What it does
- Daily or monthly blocker that helps prevent relapse
- Controlled substance?
- No9
- More
- This page
Drug: Naloxone (Narcan and other sprays)
Drug: Buprenorphine with naloxone (Suboxone)
A tablet blocks opioids for about a day; the shot for about a month
Naltrexone's half-life is about 4 hours and 6-beta-naltrexol's about 13 hours.2 One Vivitrol shot blocks opioids for about 28 days.3 Drug tests, surgery and the timing of the last dose are covered on how long naltrexone stays in your system.
Not a controlled substance, and no dependence in studies
Federal rules exclude naltrexone from the opioid schedule, so it carries none of the extra prescribing rules that apply to controlled drugs.9 It does not lead to physical or psychological dependence, and NIAAA lists it among the nonaddictive alcohol medicines.2,25 It still needs a prescription. See is naltrexone a controlled substance? and is naltrexone addictive?
Any licensed prescriber can write it
No special license or registration is needed: any practitioner licensed to prescribe medicines can prescribe it.26 NIAAA tells clinicians the alcohol medicines are "neither addicting nor complicated to prescribe," and that primary care can offer them.5 Yet in 2024, 2.5% of people in the US aged 12 and older with alcohol use disorder (about 697,000 of an estimated 28.0 million) received medication for it.27,28
You can ask your own doctor, or compare 13 online programs, their prices and whether they use generic or compounded naltrexone on where to get naltrexone online. We have full reviews of Oar Health, Reframe, Ria Health and Sunnyside.
Naltrexone through the years
| Year | Event |
|---|---|
| 1960s | Naltrexone is synthesized to block the euphoric effects of morphine1 |
| 1984 | FDA approves the tablets to block the effects of opioids1,8 |
| 1994 | FDA approves the tablets for alcohol dependence1 |
| 2006 | Vivitrol approved for alcohol dependence1,8 |
| 2009 | Embeda, a morphine capsule that also contained naltrexone, approved; now listed as discontinued8 |
| 2010 | Vivitrol approved to prevent relapse to opioid dependence1,8 |
| 2013 | Boxed liver warning removed from the ReVia tablet label21 |
| 2014 | Contrave (naltrexone with bupropion) approved for weight management8 |
| 2016 | Troxyca ER, an oxycodone capsule that also contained naltrexone, approved; now listed as discontinued8 |
| 2023 | First generic of the shot (Teva) approved; now listed as discontinued8 |
Naltrexone through the years
Year: 1960s
- Event
- Naltrexone is synthesized to block the euphoric effects of morphine1
Year: 1984
Year: 1994
- Event
- FDA approves the tablets for alcohol dependence1
Year: 2006
Year: 2009
- Event
- Embeda, a morphine capsule that also contained naltrexone, approved; now listed as discontinued8
Year: 2010
Year: 2013
- Event
- Boxed liver warning removed from the ReVia tablet label21
Year: 2014
- Event
- Contrave (naltrexone with bupropion) approved for weight management8
Year: 2016
- Event
- Troxyca ER, an oxycodone capsule that also contained naltrexone, approved; now listed as discontinued8
Year: 2023
- Event
- First generic of the shot (Teva) approved; now listed as discontinued8
Every naltrexone page on this site
About the drug
| Page | What it answers |
|---|---|
| Naltrexone dosage | Doses for alcohol, opioids, Vivitrol, targeted and low-dose use |
| How long naltrexone stays in your system | Half-life, drug tests and stopping before surgery |
| Is naltrexone a controlled substance? | Federal law, the DEA list and dependence |
| Naltrexone vs naloxone | Daily treatment vs overdose rescue |
| Naltrexone brand names | ReVia, Vivitrol, generics and the unbranded kit |
| Naltrexone and bupropion (Contrave) | The weight-management combination |
| Precipitated withdrawal | Why naltrexone, Vivitrol or Suboxone can set off sudden opioid withdrawal |
Every naltrexone page on this site: About the drug
Page: Naltrexone dosage
- What it answers
- Doses for alcohol, opioids, Vivitrol, targeted and low-dose use
Page: How long naltrexone stays in your system
- What it answers
- Half-life, drug tests and stopping before surgery
Page: Is naltrexone a controlled substance?
- What it answers
- Federal law, the DEA list and dependence
Page: Naltrexone vs naloxone
- What it answers
- Daily treatment vs overdose rescue
Page: Naltrexone brand names
- What it answers
- ReVia, Vivitrol, generics and the unbranded kit
Page: Naltrexone and bupropion (Contrave)
- What it answers
- The weight-management combination
Page: Precipitated withdrawal
- What it answers
- Why naltrexone, Vivitrol or Suboxone can set off sudden opioid withdrawal
Topic guides
| Guide | Pages in it |
|---|---|
| Alcohol use disorder | Does naltrexone work? · How long it takes to work · Drinking on naltrexone · Naltrexone vs acamprosate · Naltrexone vs disulfiram · All alcohol medicines compared |
| The Sinclair Method | Taking it only before drinking (off-label) |
| Vivitrol | Naltrexone vs Vivitrol · Vivitrol side effects |
| Naltrexone side effects | Nausea and how to manage it · Naltrexone liver tests |
| Getting naltrexone online | What it costs · Oar Health · Reframe · Ria Health · Sunnyside |
| Low-dose naltrexone | Off-label uses, evidence and prices |
| Naltrexone reviews | Experiences shared by people who took it |
Every naltrexone page on this site: Topic guides
Guide: Alcohol use disorder
Guide: The Sinclair Method
- Pages in it
- Taking it only before drinking (off-label)
Guide: Vivitrol
- Pages in it
- Naltrexone vs Vivitrol · Vivitrol side effects
Guide: Naltrexone side effects
- Pages in it
- Nausea and how to manage it · Naltrexone liver tests
Guide: Getting naltrexone online
- Pages in it
- What it costs · Oar Health · Reframe · Ria Health · Sunnyside
Guide: Low-dose naltrexone
- Pages in it
- Off-label uses, evidence and prices
Guide: Naltrexone reviews
- Pages in it
- Experiences shared by people who took it
Share your experience
Have you taken naltrexone, as a tablet, the shot or at a low dose? Tell us how it went.
Frequently asked questions
What is naltrexone used for?
It is FDA-approved for alcohol use disorder and, after detox, for opioid use disorder; low-dose and before-drinking uses are off-label. See approved and off-label uses.2,3,11
How does naltrexone work?
It blocks opioid receptors, so opioids have little effect, and it is thought to dull the reward from drinking. See how it works.2,5
Is naltrexone the same as naloxone (Narcan)?
No. Both block opioid receptors, but naloxone is a short-acting rescue drug for overdoses, while naltrexone is taken daily or monthly to prevent relapse. See naltrexone vs naloxone.2,23
Can you drink alcohol while taking naltrexone?
It causes no sickness reaction if you drink, and the tablets can be started while still drinking. See drinking on naltrexone.2,5
What should I avoid while taking naltrexone?
Avoid all opioids, including opioid cough and diarrhea medicines, and never take extra opioids to get past the block. See risks and interactions and the full list in what to avoid on naltrexone.2
How much weight can you lose with naltrexone?
Naltrexone alone is not approved for weight loss. In a 56-week trial of Contrave, which adds bupropion, average weight loss was 5.4% of body weight, against 1.3% on placebo. See naltrexone and bupropion (Contrave).13
Why don't more doctors prescribe naltrexone?
NIAAA calls alcohol medicines vastly underused and says some patients hesitate because of misinformation; no special license is needed. See who can prescribe it.5,26
Is there a generic version of naltrexone?
Yes. The tablets are sold only as generics; the shot's only generic is listed as discontinued. See tablets and the shot.8
How we checked
- Drug facts come from the current tablet, Vivitrol and Contrave labels on DailyMed. Approval dates come from FDA application records and SAMHSA's TIP 63.1-3,8,13
- Evidence comes from the 2023 AHRQ review, Cochrane reviews, one Vivitrol opioid trial and a 2019 laboratory meta-analysis, read as abstracts or summaries.4,6,15-17
- Every figure was matched to a saved copy of its source on October 17, 2026.
Related guides
References
29 sources, numbered in the order they are first cited (AMA style). Each is labelled by type so you can weigh it; commercial and media sources are never the only support for a clinical claim.
- 1.Substance Abuse and Mental Health Services Administration. Medications for Opioid Use Disorder. Treatment Improvement Protocol (TIP) Series 63. Publication No. PEP21-02-01-002. SAMHSA; 2021. Accessed October 17, 2026. https://library.samhsa.gov/sites/default/files/pep21-02-01-002.pdfClinical guideline
- 2.Naltrexone hydrochloride tablets USP, 50 mg. Prescribing information. SpecGx LLC; revised May 2026. DailyMed SPL version 15. Accessed October 17, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06ff2d5a-e62b-4fa4-bbdb-01938535bc65FDA drug label
- 3.Vivitrol (naltrexone for extended-release injectable suspension). Prescribing information and Medication Guide. Alkermes, Inc.; revised May 2026. DailyMed SPL version 39. Accessed October 17, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cd11c435-b0f0-4bb9-ae78-60f101f3703fFDA drug label
- 4.McPheeters M, O'Connor EA, Riley S, et al. Pharmacotherapy for alcohol use disorder: a systematic review and meta-analysis. JAMA. 2023;330(17):1653-1665. doi:10.1001/jama.2023.19761Systematic review / meta-analysis · Our summary of this study
- 5.Recommend evidence-based treatment: know the options. In: Core Resource on Alcohol. National Institute on Alcohol Abuse and Alcoholism. Revised May 8, 2025. Accessed October 17, 2026. https://www.niaaa.nih.gov/health-professionals-communities/core-resource-on-alcohol/recommend-evidence-based-treatment-know-optionsGovernment source
- 6.Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, Verster A. Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database Syst Rev. 2011;(4):CD001333. doi:10.1002/14651858.CD001333.pub4Systematic review / meta-analysis · Our summary of this study
- 7.Substance Abuse and Mental Health Services Administration. Prescribing Pharmacotherapies for Patients With Alcohol Use Disorder. Advisory. Publication No. PEP20-02-02-015. SAMHSA; 2021. Accessed October 17, 2026. https://library.samhsa.gov/sites/default/files/PEP20-02-02-015.pdfClinical guideline
- 8.Drugs@FDA application records for naltrexone products (including NDA 018932, NDA 021897, NDA 200063, NDA 022321, NDA 207621 and ANDA 213195). openFDA. US Food and Drug Administration. Accessed October 17, 2026. https://api.fda.gov/drug/drugsfda.json?search=products.active_ingredients.name:%22NALTREXONE%22&limit=100Government source
- 9.Schedule II, 21 CFR §1308.12 (2026). eCFR version as of October 1, 2026. Accessed October 17, 2026. https://www.ecfr.gov/current/title-21/chapter-II/part-1308/section-1308.12Government source
- 10.Vivitrol prices, coupons, copay cards & patient assistance. Drugs.com. Accessed October 17, 2026. https://www.drugs.com/price-guide/vivitrolCommercial source · Discount-card cash prices; not valid with insurance; prices change.
- 11.Gouda AHK, Aitcheson NEC, Steadman KJ. Low-dose naltrexone: what is the evidence? A narrative review. Adv Ther. 2026;43(7):2852-2870. doi:10.1007/s12325-026-03612-5Narrative review
- 12.NDC directory: generic name naltrexone. openFDA. US Food and Drug Administration. Accessed October 17, 2026. https://api.fda.gov/drug/ndc.json?search=generic_name:naltrexone&limit=100Government source
- 13.Contrave (naltrexone hydrochloride and bupropion hydrochloride) extended-release tablets. Prescribing information. Nalpropion Pharmaceuticals LLC; revised November 2025. DailyMed SPL version 27. Accessed October 17, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=485ff360-32c8-11df-928b-0002a5d5c51bFDA drug label
- 14.American Psychiatric Association. Guideline statement summary. In: The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder. American Psychiatric Association Publishing; 2018. Accessed October 17, 2026. doi:10.1176/appi.books.9781615371969Clinical guideline
- 15.Ray LA, Green R, Roche DJO, Magill M, Bujarski S. Naltrexone effects on subjective responses to alcohol in the human laboratory: a systematic review and meta-analysis. Addict Biol. 2019;24(6):1138-1152. doi:10.1111/adb.12747Systematic review / meta-analysis · Our summary of this study
- 16.Rösner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M. Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev. 2010;(12):CD001867. doi:10.1002/14651858.CD001867.pub3Systematic review / meta-analysis · Our summary of this study
- 17.Krupitsky E, Nunes EV, Ling W, Illeperuma A, Gastfriend DR, Silverman BL. Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial. Lancet. 2011;377(9776):1506-1513. doi:10.1016/S0140-6736(11)60358-9Randomized controlled trial · Our summary of this study
- 18.Naltrexone for extended-release injectable suspension (kit). Prescribing information. Amneal Pharmaceuticals LLC; January 2026. DailyMed SPL version 1. Accessed October 17, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6de5637f-d527-4228-af1a-3aae71155cb5FDA drug label · Sold under Vivitrol's NDA 021897 without the brand name. We could not verify a price or current availability.
- 19.Compounding and the FDA: questions and answers. US Food and Drug Administration. Content current as of September 16, 2025. Accessed October 17, 2026. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answersGovernment source
- 20.National Institute for Health and Care Excellence. Alcohol-Use Disorders: Diagnosis, Assessment and Management of Harmful Drinking (High-Risk Drinking) and Alcohol Dependence. Clinical guideline CG115. Published February 23, 2011. Updated October 21, 2014. Accessed October 17, 2026. https://www.nice.org.uk/guidance/cg115/chapter/RecommendationsClinical guideline
- 21.US Food and Drug Administration. Revia (naltrexone HCl) tablets: detailed view: safety labeling changes approved by FDA Center for Drug Evaluation and Research (CDER). MedWatch Safety Information. October 2013. Internet Archive capture November 9, 2015. Accessed October 17, 2026. https://web.archive.org/web/20151109023859/http://www.fda.gov/safety/medwatch/safetyinformation/ucm374896.htmGovernment source · Archived copy (Internet Archive).
- 22.988 Suicide & Crisis Lifeline. Accessed October 17, 2026. https://988lifeline.org/Nonprofit organization
- 23.FDA approves first over-the-counter naloxone nasal spray. News release. US Food and Drug Administration. March 29, 2023. Accessed October 17, 2026. https://www.fda.gov/news-events/press-announcements/fda-approves-first-over-counter-naloxone-nasal-sprayGovernment source
- 24.Controlled substances – alphabetical order. US Drug Enforcement Administration, Diversion Control Division. August 27, 2026. Accessed October 17, 2026. https://www.deadiversion.usdoj.gov/schedules/orangebook/c_cs_alpha.pdfGovernment source
- 25.Understanding alcohol use disorder. National Institute on Alcohol Abuse and Alcoholism. Updated January 2025. Accessed October 17, 2026. https://www.niaaa.nih.gov/publications/brochures-and-fact-sheets/understanding-alcohol-use-disorderGovernment source
- 26.Naltrexone. Substance Abuse and Mental Health Services Administration. Updated December 22, 2025. Accessed October 17, 2026. https://www.samhsa.gov/substance-use/treatment/options/naltrexoneGovernment source
- 27.Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Table 5.21B: received medications for alcohol use disorder (MAUD) in past year: among people aged 12 or older; received MAUD in past year: among people aged 12 or older with past year alcohol use disorder; by demographic characteristics, percentages, 2023 and 2024. In: Results From the 2024 National Survey on Drug Use and Health: Detailed Tables. SAMHSA; 2025. Accessed October 17, 2026. https://www.samhsa.gov/data/sites/default/files/reports/rpt56484/NSDUHDetailedTabs2024/NSDUHDetailedTabs2024/2024-nsduh-detailed-tables-sect5pe.htmGovernment source
- 28.Alcohol treatment in the United States: age groups and demographic characteristics. National Institute on Alcohol Abuse and Alcoholism. Updated March 2026. Accessed October 17, 2026. https://www.niaaa.nih.gov/alcohols-effects-health/alcohol-topics/alcohol-facts-and-statistics/alcohol-treatment-united-states-age-groups-and-demographic-characteristicsGovernment source
- 29.SAMHSA's National Helpline. Substance Abuse and Mental Health Services Administration. Updated June 9, 2023. Accessed October 17, 2026. https://www.samhsa.gov/find-help/helplines/national-helplineGovernment source
Medical disclaimer
This page is for general information only and is not medical advice. It does not replace advice from your own clinician or pharmacist. Don't start, stop or change a medicine without talking to your prescriber. If you drink heavily every day, stopping suddenly can be dangerous; get medical advice first. If you use opioids, starting naltrexone in either form can cause sudden, severe withdrawal. For free, confidential treatment referrals 24 hours a day, call SAMHSA's National Helpline at 1-800-662-4357.29
Full medical disclaimer.